Decision Diagnostics Emerges Victorious in End to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Decision Diagnostics Emerges Victorious in End to Acrimonious Patent Litigation With Divisions of Johnson + Johnson

LOS ANGELES, CA--(Marketwired - Jun 2, 2016) - Decision Diagnostics Corp. ( OTC PINK : DECN ), the manufacturer, quality plan administrator and the exclusive worldwide sales, service and regulatory processes agent for GenStrip™ 50 and the GenUltimate!™ glucose test strips, both designed to work with the market leading Johnson & Johnson's ("J&J") LifeScan OneTouch Ultra family of glucose testing meters, and the in-development GenSure!™ and GenChoice!™ glucose test strips targeted to the U.S. and/or developing world markets, today reports the completion of term negotiations and the signing of a final settlement to conclude all patent litigation filed by J&J against PharmaTech Solutions and its parent company Decision Diagnostics.

As the company's loyal shareholders are well aware, Decision Diagnostics and its subsidiary PharmaTech Solutions were reluctantly drawn into this lengthy patent litigation journey nearly five years ago, with two divisions of Johnson + Johnson. The management team at DECN was deeply knowledgeable and extensively experienced in glucose test strip technology. Prior to market introduction, it was the shared internal opinion that the companies' GenStrip product was independent of any current product patent and infringed on no proprietary intellectual property. Extensive research by expert patent attorneys was contracted by the company and its insurers to corroborate that belief.

Fortified with comprehensive legal assurances, GenStrip was targeted for launch and commercialization. Market planning and projections strongly indicated rapid growth and broad distribution. Contracts were negotiated with critical brick and mortar chain drug and mass merchandisers, as well as pharmaceutical group purchasing organizations. Print and television advertising was created and a supportive promotional campaign was launched. Revenue began flowing and DECN's market awareness quotient was elevating.

Growth and expansion was abruptly interrupted by the now broadly known meritless litigation and intimidation barrage of our customers leveled by the divisions of Johnson + Johnson (LifeScan/J&J). A "scorched earth" campaign of lies, threats and intimidation coupled with tens of millions of dollars in allocated legal expenditures to finance unfounded patent infringement allegations functionally curtailed further GenStrip market expansion. The relentless legal assaults forced our transition from an aggressive, vital market focused entity to allocation of a preponderance of available human and financial resources towards refuting each lie, countering every threat, overcoming false testimony, and defeating all accusations. The corporations' directors and senior management in conjunction with its litigation patent attorneys evaluated the legal and market environment concluding that the only just recourse was to be vindicated by the courts and to ultimately defeat J&J/LifeScan in the marketplace of free competition. It was appreciated at the time that J&J would resort to any tactic in order to prevail. There was no action, lie, provision of false witness, delay or accusation to which they would fail to stoop to defeat our just position as a viable competitor. They were expected to behave egregiously and abominably; they proceeded to exceed all of the worst expectations. 

More than four years of searing, vitriolic and relentless attacks and prevarications were not only endured but thoroughly rebuffed. The U.S. Appeals Court for the Federal Circuit on May 10, 2016 finally terminated the J&J/LifeScan meritless and illicit legal campaign through a unanimous rejection of the J&J petition for en banc rehearing requested in a desperate attempt to preserve their foundational patent. That ruling, and the Mandate that followed nine days later, not only rendered any J&J claims to patentability null and void, but also shattered their erected customer intimidation barrier to the GenStrip market reentry.

As has been previously reported, J&J/LifeScan and DECN and PharmaTech were ordered by the district court judge to participate in mandatory mediation to resolve all patent infringement and trademark violation litigation filed by J&J/LifeScan against PharmTech Solutions, the subsidiary of DECN. Those mediation sessions were held on April 26, 2016 and conducted by the Chief Magistrate of the Federal District Court. At the close of the mediation Decision Diagnostics/PharmaTech Solutions agreed in principle to terms that would dismiss all litigation by J&J against the companies.

On May 20, PharmaTech formally agreed to the terms of a final settlement and executed an agreement to that effect. Those actions have brought to a conclusion all litigation by J&J/LifeScan against the company's PharmaTech subsidiary in pursuit of any and all claims of patent and trademark infringement. PharmaTech has been proven to be entirely innocent of each and every accusation leveled against it. J&J will pay the company for their actions a cash settlement in an amount that has been made confidential by the court. It is with great pleasure that the company hereby informs its shareholders, the investment community and followers of our company that GenStrip, GenUltimate! and its family of associated products are now free of any legal constraints, and also all threats of intimidation and retribution targeted to our customers have been removed.

"GenStrip and GenUltimate! are now officially, legally and justly available for sale," Keith Berman, PEO of DECN and President of PharmaTech Solutions, Inc. commented. "It is over and we have unconditionally won. The long, seemingly endless legal carnage that we all have been forced to weather is now behind us. As a company, we faced a crucial decision once the courts had ruled on the veracity of our claims and the legitimacy of our position. We evaluated the benefits of continuing legal pursuit of a maximum settlement of damages in California versus the associated costs of that pursuit in financial and human resource allocation, and also in critical opportunity cost. The decision that was made responded to the fundamental issue that prompted our defense and drove our continued pursuit. This odyssey was governed and sustained by the conviction of our unencumbered right to market our ' Gen ' family of test strips to whomever, and wherever, we chose. That right is now undisputed and we have unanimously decided to immediately exercise it. The maximization of penalty and damage collection will appropriately be derived from J&Js own product revenue stream. We intend to beat them in the marketplace, own their market share and capture their earnings."

Although the company believes we had been justly compensated through the settlement, and extended litigation may have expanded the amount, we came to the realization that our singular immediate objective was manufacturing and delivering low priced, quality strips to diabetics. Our entire growing organization is alive and eager to directly engage J&J/LifeScan in a free and open market. The company capitalized on its functional market hiatus by extensively planning and developing a suite of new products and the protection of our own technologies through patent infringement litigation against J&J. These new additions are scheduled for release throughout 2016 with additional product and product line extensions anticipated in 2017.

Mr. Berman concluded, "Once again, we have won a resounding, and frankly, startling series of legal victories. Our little Pharma Tech has crushed a healthcare leviathan. We have metaphorically brought it to its knees and forced it to beg for forgiveness. However, the resources that we were forced to expend in pursuit of this result were far from modest. We learned from this confrontation that we are competing in a litigious landscape dominated by the large and wealthy. As a result, our planned new product introductions will be fortified with an extensive legal defense financial armada and partnership participation by specialty legal (case) financing funds. A large litigation financing fund has been contracted and additional IP defense insurance policies have been established to protect against possible future baseless allegations. In fact, the entire cash settlement award from J&J has been directly transferred at our request into this fund, maintained by our counsels. In effect, J&J is underwriting our future litigation victories and our future litigation defenses. Some might refer to this as justice."

Forward-Looking Statements:   This release contains the Company's forward - looking statements which are based on management's current expectations and assumptions as of May 31, 2016, regarding the Company's business and performance, its prospects, current factors, the economy and other future conditions and forecasts of future events, circumstances and results.

CONTACT INFORMATION Decision Diagnostics Corp. Keith Berman (805) 446-2973 info@decisiondiagnostics.com www.genultimate.com www.decisiondiagnostics.com www.pharmatechdirect.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RBC Grabs Top Honors for Sustainable Investing Leadership

Updated Category News Views 70

A New Feather in RBC's Cap RBC Wealth Management has racked up more accolades, crowned as the Best Private Bank in Canada and celebrated for its prowess in impact and sustainable investing on the global stage. These distinctions flew in courtesy of the PWM Global Private Banking Awards—a heavyweight recognition in the wealth management world. Award Winning Strategy in...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 279

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Parallels Desktop Tops 2026 Picks for Windows on Mac

Updated Category News Views 59

Diving into the Cross-Platform Conundrum Now, I've been in the trenches long enough to know that when companies start relying on Mac computers but can't ditch their essential Windows apps, they're bound to hit a digital brick wall. Picture this—accounting, enterprise management, all that jazz that still needs Windows to function. For those jumping between these two...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 100

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 115

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Trades Workforce Shortage Costs Wallop U.S. Economy

Updated Category News Views 36

The Forgotten Backbone of America Don't sleep on this: America's got itself a trade worker crisis, and it's not just a numerical hiccup. We’re down nearly 1.9 million skilled trades workers, and that's a gut punch to the economy—a hefty $1.2 billion a day in GDP loss. These are the folks who keep the wheels greased, the lights on, and the goods flowing. Without them,...

Continue Reading
Gayatri Pariwar Celebrates 100 Years with Massive Yoga Event

Updated Category News Views 72

An Impressive Centenary for Gayatri Pariwar Sometimes, you get hit by a wave so big you can't ignore it, and Gayatri Pariwar's centennial festival in New Delhi was one such tsunami. Picture this: countless souls gathered to mark a hundred years of spiritual and social reform, not just with chants and talks, but through an awe-inspiring mass yoga event. In my decades...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 62

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
Dar Global Expands Jeddah Portfolio with $267M Project

Updated Category News Views 120

Dar Global's Big Jeddah Move: A $267M Bet Alright, let's dive into what Dar Global's been up to in Saudi Arabia. They've just announced a whopping SAR 1 billion development project in Jeddah, bringing an international luxury brand to the city with an exclusive co-branded residential concept. Now that's something to chew on for any investor eyeing the Middle East's real...

Continue Reading
Ozelle Unveils AI-Powered Hematology Tool at MEDICA 2026

Updated Category News Views 116

Pioneering a New Era in Hematology In the fast-paced world of blood analysis, standing still means being left in the dust. Ozelle, with its AI-powered innovative tool, is making waves at MEDICA 2026 in Düsseldorf. Meet O-Cyte 1, an automated hematology analyzer that's merging high-resolution cell imaging with routine CBC (Complete Blood Count) testing. Sounds like...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Smart Waste Management Market Growth Insights

Updated Category News Views 124

Overview of the Smart Waste Management Market In recent years, the smart waste management market has garnered substantial attention, projected to transition from $2.2 billion in valuation to an impressive $8.3 billion. This surge reflects a remarkable compound annual growth rate (CAGR) of 15.6% from 2024 to 2032. The driving force behind this growth stems from increasing...

Continue Reading
Exploring the Collaborative Spirit at the China-US Event

Updated Category News Views 150

Celebrating Cultural Connections The recent 'My China Album' event highlighted the importance of cultural exchanges between the United States and China, focusing on the shared journeys and experiences of citizens from both nations. Strengthening Relations through Understanding During this special occasion, the ambassador emphasized the collaborative spirit that can propel...

Continue Reading
Exciting New Active Adult Community Launches in Central Oregon

Updated Category News Views 143

Welcoming Active Adults to Dry Canyon Introducing Dry Canyon, an extraordinary gated community designed specifically for those aged 55 and better. This remarkable development offers active adults a perfect blend of resort-style living and scenic beauty, all nestled in the heart of Central Oregon. As part of this celebration, Lennar, a well-respected name among...

Continue Reading
XTI Aerospace Announces Upcoming Town Hall for Stakeholders

Updated Category News Views 153

XTI Aerospace Invites Stakeholders to Upcoming Town Hall Updates on Tri-Fan 600, Valkyrie AI and Vanguard Platform ENGLEWOOD, Colo. – XTI Aerospace, Inc. (NASDAQ: XTIA) is at the forefront of advancing vertical flight technologies. The company is making exciting progress with its next-generation vertical takeoff and landing (VTOL) aircraft, the TriFan 600. XTI Aerospace...

Continue Reading
Big Lots Launches Discounts and Donations for Vets in November

Updated Category News Views 47

Big Lots Supports Veterans and Active Military with November Campaigns Every November, Big Lots makes a concerted effort to give back to veterans and active military members. This initiative is a part of their commitment to recognizing the sacrifices made by those who serve our country. Highlighting their respect for military service, Big Lots introduces various discounts...

Continue Reading